US Stocks
/
Soligenix, Inc. Share Price
Soligenix, Inc. Share Price

Soligenix, Inc. Share Price

NASDAQ: SNGX | Micro Cap
$0.34
+$0.34 (--%) Last updated on 08 Oct, 2026 | 21:50 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Soligenix, Inc. Stock Performance

Open
$0.35
Prev. Close
N/A
Circuit Range
N/A
Day Range
$0.34 - $0.35
Year Range
$0.28 - $1.96
Volume
932
Average Traded
$0.35

Soligenix, Inc. Share Price Chart

$0.34$0.35
L
Show Current Price
H

Soligenix, Inc. Stock Fundamentals & Key Indicators

Market Cap
$1.79M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.47
Revenue (TTM)
$0.00
Return On Equity (TTM)
-154.08%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
21.34%

Soligenix, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$2.53-$2.90-$2.82-$1.99
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-14.62%2.76%29.43%

Soligenix, Inc. Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.95$0.84$0.12$0.00
Net Profit-$13.80-$6.14-$8.27-$11.08
Net Profit Margin-1452.63%-730.95%-6891.67%N/A
Income ChangeN/A55.51%-34.69%-33.98%

About Soligenix, Inc.

Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. The company operates through two business segments namely: The Public Health Solutions business segment includes development programs for RiVax, a ricin toxin vaccine candidate, GX943, a therapeutic candidate for antibiotic resistant and emerging infectious disease and various vaccine programs, including a program targeting filoviruses and CiVax; and The Specialized BioTherapeutics business segment is developing and moving toward potential commercialization of HyBryte, utilizing topical synthetic hypericin activated with safe visible light for the treatment of cutaneous T-cell lymphoma (CTCL).

Soligenix, Inc. Historical Returns

MonthOpenCloseChange %
Oct 2026
$0.36
$0.34
-4.70%
Sep 2026
$0.38
$0.36
-10.84%
Aug 2026
$0.37
$0.41
+9.14%
Jul 2026
$0.41
$0.37
-7.69%
Jun 2026
$0.84
$0.40
-56.29%
May 2026
$0.35
$0.92
+163.43%
Apr 2026
$1.21
$0.35
-70.34%
Mar 2026
$1.15
$1.18
+0.00%
Feb 2026
$1.25
$1.18
-5.60%
Jan 2026
$1.36
$1.25
-6.72%
Dec 2025
$1.57
$1.34
-15.99%
Nov 2025
$1.49
$1.59
+2.90%

SNGX Share Price FAQs

What is Soligenix, Inc. share price today?

chevron-up
Soligenix, Inc. share price today is $0.34 as on October 8, 2026 at 9:50 pm IST.

What is the 52 week high and 52 week low of Soligenix, Inc. stock?

chevron-up
The 52 week high of Soligenix, Inc. stock is $1.96, while the 52 week low is $0.28 as of 8 Oct '26.

What is SNGX's market capitalisation today?

chevron-up
SNGX market capitalisation is $1.79M as of October 10, 2026, at 12:42 am IST.

What is SNGX's net income for the last quarter?

chevron-up
SNGX's net income for the last quarter is -1.99B USD.

What is the 5 year returns of SNGX?

chevron-up
The 5 year returns of SNGX is -99.86% as on 8 Oct '26.

What is the high & low stock price of SNGX today?

chevron-up
SNGX stock price hit a high of $0.35 and low of $0.34 as of 8 Oct '26.

Can I buy SNGX shares in India?

chevron-up
Yes. You can buy SNGX in India by opening an international trading account.